Product Category
Newest Products
Human VEGF R3/Flt-4 ELISA Kit
$350.00 – $450.00
| Sample Type | Serum, plasma, cell culture supernatant, and other biological samples |
|---|---|
| Sample Volume | 100 μL |
| Sensitivity | 15.35 pg/mL |
| Range | 0.31 ng/mL – 20 ng/mL |
| Assay Time | 3.5 h |
| Recovery | 79% – 110% |
| Average Recovery | 0.95 |
| Intra Precision | 4.3% – 9.0% |
| Inter-Precision | 7.2% – 10.7% |
| Platform | ELISA |
| Plate | Detachable 96-well plate |
| Size | 96T/48T |
| Storage | If the reagent kit is unopened, it should be stored at 4℃. However, if it has been opened, the standard solution should be stored at -20℃, while the other components should be stored at 4℃. |
| Delivery | 4℃ blue ice transportation |
| Components | 96-well polystyrene enzyme-linked immunosorbent assay (ELISA) plate coated with anti-VEGF R3/Flt-4 monoclonal antibody Human VEGF R3/Flt-4 freeze-dried standard VEGF R3/Flt-4 detect Antibody Standard Diluent Assay Buffer(10×) Substrate TMB Stop Solution Washing Buffer(20×) Sealing Film |
| Assay Principle | This kit utilizes the double antibody sandwich enzyme-linked immunosorbent assay (ELISA) detection technique.Specific anti-human VEGF R3 antibodies are precoated on a high-affinity ELISA plate. Standard samples, test samples, and the detection antibody labeled with horseradish peroxidase are added to the wells of the ELISA plate. After incubation, VEGF R3 present in the samples binds to the solid-phase antibodies and the detection antibodies. After washing, a colorimetric substrate, TMB, is added and the plate is incubated in the dark for color development. The intensity of the color reaction is directly proportional to the concentration of VEGF R3 in the samples.A stop solution is added to terminate the reaction, and the absorbance value is measured at a wavelength of 450 nm (with a reference wavelength range of 570-630 nm). |
Targets
FLT4
FLT4 Target Infomation Overview
- Target Symbol: FLT4, fms related receptor tyrosine kinase 4
- Gene Groups: Receptor tyrosine kinases; I-set domain containing
- Alias: VEGFR3; PCL; VEGFR-3
- Alias Names: vascular endothelial growth factor receptor 3; VEGF receptor-3; Feline McDonough Sarcoma (FMS)-like tyrosine kinase 4; primary congenital lymphedema; fms-related tyrosine kinase 4; fms related tyrosine kinase 4
FLT4, fms related receptor tyrosine kinase 4 Target Infomation by Species
[su_tabs][su_tab title=”Human” disabled=”no” anchor=”” url=”” target=”blank” class=”tab-human”]
Human FLT4 Target Information
- Target Symbol: FLT4, fms related receptor tyrosine kinase 4
- Alias:
- CHTD7
- Feline McDonough Sarcoma (FMS)-like tyrosine kinase 4
- FLT-4
- FLT41
- fms related tyrosine kinase 4
- fms-like tyrosine kinase 4
- fms-related tyrosine kinase 4
- LMPH1A
- LMPHM1
- PCL
- primary congenital lymphedema
- soluble VEGFR3 variant 1
- soluble VEGFR3 variant 2
- soluble VEGFR3 variant 3
- tyrosine-protein kinase receptor FLT4
- vascular endothelial growth factor receptor 3
- VEGF receptor-3
- VEGFR-3
- VEGFR3
- NCBI_Gene: 2324
- UniProtKB: P35916
Human FLT4 Predicted Functions
Enables several functions, including protein homodimerization activity; protein phosphatase binding activity; and vascular endothelial growth factor-activated receptor activity. Involved in several processes, including positive regulation of intracellular signal transduction; positive regulation of macromolecule metabolic process; and protein phosphorylation. Acts upstream of or within vascular endothelial growth factor receptor signaling pathway. Located in cytosol; nucleoplasm; and plasma membrane. Part of receptor complex. Implicated in hereditary lymphedema IA. Biomarker of lymphangioma and systemic scleroderma.
[/su_tab]
[su_tab title=”Mouse” disabled=”no” anchor=”” url=”” target=”blank” class=”tab-mouse”]
Mouse Flt4 Target Information
- Target Symbol: Flt4, FMS-like tyrosine kinase 4
- Alias:
- AI323512
- Chy
- chylous ascites
- expressed sequence AI323512
- Flt-4
- VEGFR-3
- VEGFR3
- NCBI_Gene: 14257
Mouse Flt4 Predicted Functions
Enables vascular endothelial growth factor-activated receptor activity. Involved in lymphangiogenesis; regulation of blood vessel remodeling; and sprouting angiogenesis. Acts upstream of or within lung alveolus development; positive regulation of cell population proliferation; and respiratory system process. Predicted to be located in cytosol; nucleoplasm; and plasma membrane. Predicted to be part of receptor complex. Predicted to be integral component of plasma membrane. Is expressed in several structures, including alimentary system; branchial arch; cardiovascular system; central nervous system; and extraembryonic component. Used to study hereditary lymphedema. Human ortholog(s) of this gene implicated in hereditary lymphedema IA. Orthologous to human FLT4 (fms related receptor tyrosine kinase 4).
[/su_tab]
[su_tab title=”Rat” disabled=”no” anchor=”” url=”” target=”blank” class=”tab-rat”]
Rat Flt4 Target Information
- Target Symbol: Flt4, Fms related receptor tyrosine kinase 4
- Alias:
- FLT-4
- FMS-like tyrosine kinase 4
- fms-related tyrosine kinase 4
- LOC360235
- tyrosine-protein kinase receptor FLT4
- vascular endothelial growth factor receptor 3
- VEGFR-3
- Vegfr3
- NCBI_Gene: 114110
Rat Flt4 Predicted Functions
Enables growth factor binding activity and vascular endothelial growth factor-activated receptor activity. Involved in positive regulation of cell growth and vascular endothelial growth factor receptor signaling pathway. Predicted to be located in cytosol; nucleoplasm; and plasma membrane. Predicted to be part of receptor complex. Predicted to be integral component of plasma membrane. Human ortholog(s) of this gene implicated in hereditary lymphedema IA. Orthologous to human FLT4 (fms related receptor tyrosine kinase 4).
[/su_tab][/su_tabs]
FLT4 Target News
[catlist tags=”flt4″ template=targetnews thumbnail=yes thumbnail_class=”related-post-media clr” thumbnail_size=833]
